These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11696365)

  • 1. Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion.
    Lambeir AM; Durinx C; Proost P; Van Damme J; Scharpé S; De Meester I
    FEBS Lett; 2001 Nov; 507(3):327-30. PubMed ID: 11696365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice.
    Ahrén B; Hughes TE
    Endocrinology; 2005 Apr; 146(4):2055-9. PubMed ID: 15604213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE; Tatsuno I; Miyata A; Arimura A
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV.
    de Meester I; Lambeir AM; Proost P; Scharpé S
    Adv Exp Med Biol; 2003; 524():3-17. PubMed ID: 12675218
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).
    Miyata A; Jiang L; Dahl RD; Kitada C; Kubo K; Fujino M; Minamino N; Arimura A
    Biochem Biophys Res Commun; 1990 Jul; 170(2):643-8. PubMed ID: 2383262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective insulin secretion during total parenteral nutrition in rat and its normalization by pituitary adenylate cyclase-activating polypeptide 27.
    Salehi A; Qader SS; Ekblad E; Ekelund M
    Regul Pept; 2004 Jun; 119(1-2):83-91. PubMed ID: 15093701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I; Gottschall PE; Arimura A
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.
    Buljevic S; Detel D; Pucar LB; Mihelic R; Madarevic T; Sestan B; Varljen J
    Rheumatol Int; 2013 Nov; 33(11):2867-74. PubMed ID: 23864142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
    Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
    Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38).
    Zhu L; Tamvakopoulos C; Xie D; Dragovic J; Shen X; Fenyk-Melody JE; Schmidt K; Bagchi A; Griffin PR; Thornberry NA; Sinha Roy R
    J Biol Chem; 2003 Jun; 278(25):22418-23. PubMed ID: 12690116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide truncation by dipeptidyl peptidase IV: a new pathway for drug discovery?
    Scharpé S; De Meester I
    Verh K Acad Geneeskd Belg; 2001; 63(1):5-32; discussion 32-3. PubMed ID: 11284388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice.
    Baticic L; Detel D; Kucic N; Buljevic S; Pugel EP; Varljen J
    J Cell Biochem; 2011 Nov; 112(11):3322-33. PubMed ID: 21751235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation.
    Wagner L; Kaestner F; Wolf R; Stiller H; Heiser U; Manhart S; Hoffmann T; Rahfeld JU; Demuth HU; Rothermundt M; von Hörsten S
    Neuropeptides; 2016 Jun; 57():21-34. PubMed ID: 26988064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
    Bodart V; Babinski K; Ong H; De Léan A
    Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of vasoactive intestinal polypeptide, neuropeptide-Y and substance P and their effects on insulin secretion from the in vitro pancreas of normal and diabetic rats.
    Adeghate E; Ponery AS; Pallot DJ; Singh J
    Peptides; 2001 Jan; 22(1):99-107. PubMed ID: 11179603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions.
    Shivers BD; Görcs TJ; Gottschall PE; Arimura A
    Endocrinology; 1991 Jun; 128(6):3055-65. PubMed ID: 2036976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on amylase secretion from guinea pig pancreatic acini.
    Kitagawa M; Naruse S; Ishiguro H; Hayakawa T; Nokihara K
    Biomed Pept Proteins Nucleic Acids; 1995; 1(2):73-6. PubMed ID: 9346857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.